Key takeaways
Access to all written pleadings and evidence requires a concrete, verifiable and legally relevant reason
A request according to Rule 262.1(b) RoP for access to written pleadings and evidence by a member of the public requires a concrete, verifiable and legally relevant reason. The wish of a natural person to form an opinion on the validity of a patent out of a personal and a professional interest is not a legitimate reason as required by Rule 262.1(b) RoP. The reasons to be provided in the request must pertain to the reason(s) for access to the requested information per se. This applies regardless of whether there is confidential information contained in the written pleadings and evidence.
Division
Central Division (Section Munich)
UPC number
UPC_CFI_1/2023
Type of proceedings
Revocation action, Rule 262.1(b) RoP request
Parties
Relevant proceeding parties of main proceedings (revocation action):
Claimants:
Sanofi-Aventis Deutschland GmbH, Brüningstrasse 50, 65926 Frankfurt, Germany
Sanofi-Aventis Groupe, 82 Avenue Raspail, 94250 Gentilly, France
Sanofi Winthrop Industrie S.A., 82 Avenue Raspail, 94250 Gentilly, France
Defendant:
Amgen, Inc., One Amgen Center Drive, CA 91320-1799 Thousand Oaks, US
Patent(s)
EP 3 666 797
Jurisdictions
Body of legislation / Rules
Rule 262 RoP
